Navigation Links
Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs

ST. PAUL, Minn., Oct. 10, 2011 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, has met high standards of pharmacy cost transparency, earning its 2012 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) certification from the HR Policy Association. This is the fifth consecutive year Prime has received this certification.

TIPPS certification is given annually to pharmacy benefit managers (PBMs) that have agreed to provide pharmacy cost information to the association's 60 member companies, who purchase pharmacy benefits for more than five million Americans. Prime was one of just four PBMs that agreed to a set of comprehensive requirements for disclosure of supply costs and revenue sources, and also provided actual average inventory cost (AAIC) for mail service drugs, earning it the HR Policy Association's Tier One Certification for 2012.

"At Prime, we are committed to an approach that integrates medical and pharmacy as well as a philosophy of transparency," said Eric Elliott, president and chief executive officer of Prime. "TIPPS certification continues to be an important recognition for Prime, and we believe that aligning with our clients at mail as well as retail demonstrates our intent to deliver the lowest possible cost of care for clients and their members."

The TIPPS program requires PBMs to provide transparency in reporting acquisition costs, home delivery costs, pass-through of pharmacy revenue, specialty pharmacy drug costs, plan management and consumer engagement efforts. Participating PBMs also grant the association the right to audit the organization in each of these areas. The program's standards promote contracting that makes it easier for employers, their beneficiaries and dependents to understand the true price of a drug and highlight the true value PBMs bring to health care.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics Launches CareCentered Contracting™ Program
2. Wasatch Pediatrics Selects Phreesia and Greenway PrimeSUITE to Streamline its Workflow and Increase Cash Flow
3. Greenways Remote Clinic PrimeMOBILE Available on Apples iPad
4. Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry
5. PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA
6. Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per Prescription
7. Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
8. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
9. Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement
10. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
11. TriLink BioTechnologies, Inc. Awarded European Patent for CleanAmp™ Primers
Post Your Comments:
(Date:11/24/2015)... The hope of bearing a ... IVF cycles. After failure of over 15 IVF cycles, ... all hopes that she would be able to conceive ever. But finally optimism prevailed as ... failure of over 15 IVF cycles. ... take one last attempt with Gaudium IVF Center in ...
(Date:11/24/2015)... CARLOS, Calif. , Nov. 24, 2015 ... a leader in non-invasive genetic testing and ... announced that it will present at the ... in New York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew ... the Company,s financial results, business activities and ...
(Date:11/24/2015)... 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the ... that the first patient has been enrolled in ESSA,s ... for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States and ... clinical trial, ESSA intends to demonstrate the safety, tolerability, ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... 24, 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus ... in the United States grew 400 percent between 1999 and 2010, far more than ... 37 percent of all fatal drug overdoses. (1) , While oxycodone and the extended ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Serenity Point ... a series of recent video interviews with some of the staff members at their ... the residential treatment facility, as well as some of the things that make their ...
(Date:11/24/2015)... ... 2015 , ... Chiropractic student Katie Benson received a $2,500 ... Park, Kansas. Benson, a fifth-trimester student in the university’s College of Chiropractic, accepted ... 16. , “Katie is very excited and greatly appreciative to receive the Standard ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading autism science and ... media and the generosity of people around the world. On December 1, supporters can ... give – and share the personal stories behind those gifts. , Just as ...
(Date:11/24/2015)... ... November 24, 2015 , ... World ... Fragrance by Marcelle, a cosmetic invention which offers a combination of natural essential ... in the US is worth $3 billion annually," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):